|
 |
|
Contact
Yamasaki Pharma Consulting Co.,Ltd.
President & CEO
Motohiro Yamasaki, Ph.D.
3-Chome15-19 Daiwahigashi
Kawanishi-shi, Hyogo, 666-0111 Japan
Tel: 81-72-795-0440
Fax: 81-72-795-2440
E-mail: ypc@cup.ocn.ne.jp
|
|
Introduction |
Motohiro Yamasaki, Ph.D., is the President & CEO of Yamasaki Pharma
Consulting Co.,Ltd., offering consulting services to the society of health
care industry. He graduated from Gifu Pharmaceutical University and studied
Economics at Osaka City University and Management at Oakland University.
During his professional career, he held such important posts as Senior
Corporate Executive Officer in charge of Corporate Strategy, Deputy Executive
of R&D Headquarter and Corporate Officer, General Manager of R&D
Planning and Management Division, and Head of Corporate Licensing &
Business Development at Tanabe Seiyaku Co., Ltd., one of the leading pharmaceutical
companies in Japan He served as a Board Member of two Japanese-Western
joint enterprises, RP Tanabe, Paris, France and Tanabe Marion Laboratories,
Kansas, U.S.A. He also served as Chairman of the Board of Directors of
Tanabe Research Laboratories, San Diego, U.S.A.
During his tenure at Tanabe, he concluded numerous licensing transactions and established a vast network of licensing contacts at pharmaceutical companies, as well as biotechnology companies, in the US, Europe, Japan, and Korea. He has established a worldwide reputation.
|
|
As an expert in the field of pharmaceutical R&D management and licensing,
he has authored several papers in professional journals and has been an
invited speaker at many international meetings. He served as Vice President
of Licensing Executive Society Japan (612 members), Vice Chairperson of
Health Care Products Committee at Licensing Executive Society International,
Board member of Japanese Pharmaceutical Licensing Association (442 members),
and Founder & President of Kansai Pharmaceutical Licensing Association
(250 members). He continues to actively participate in these organizations.
He also served as Chairman of Pharma Delegates (210 members) for the term
2003/2004, an association of foreign and Japanese executives from all healthcare
companies as well as any others in Japan that have a stake in the healthcare
Industry.
Dr. M. Yamasaki was honored with an award by the Governor of Osaka for his contribution to the Japanese Pharmaceutical Industry in 1998.
After 40 years in the pharmaceutical industry, he became an independent
comsultant and founded Yamasaki Pharma Consulting Co., Ltd. in 2004. |
| Available Services |
Yamasaki Pharma Consulting Co., Ltd. (YPC) will provide expert in- and
out-licensing services to the U.S. and European pharmaceutical companies,
as well as biotechnology companies, that want to acquire new drugs, drug
candidates or technologies from Japan, or to seek a licensee or partner
for development and commercialization of their new drugs, drug candidates
or technologies in Japan.
The out-licensing services provided by YPC include analysis of market potential, cost estimation of development and commercialization, regulatory requirements, competitive analysis and valuation of products or technologies to be licensed to the Japanese market. YPC will prepare Executive Summaries thereof with recommendation of the most appropriate out-licensing structure and strategy. YPC is available to identify potential partners, make the initial contact, screen candidates, arrange meetings for discussion, and assist in licensing negotiations with a Japanese company.
|
|
The in-licensing services provided by YPC include searching for new drugs, drug candidates and technologies being developed in Japan, confirming the availability of licensing to the U.S. and Europe, and assisting clients in doing due diligence and negotiationng to consummate the acquisition of products or technologies of clientsf interest.
YPC is available to assist clients with any specific part of the in- and out- licensing process or to undertake the entire process. YPCfs primary objective of services is to make clientsf own efforts more efficient and much more successful in performing licensing in Japan.
YPC also offers strategic advisory services ranging from partnering and aligning to mergers, acquisitions, divestitures and business development consultancy that clients desire to have from regional experts in Japan.
|
Distinguished Features of YPC |
* YPC will provide expert advice for licensing and business development in Japan, based on 40 years of experience in licensing, business development, R&D planning and corporate management at a leading Japanese pharmaceutical company, as well as experience in running Japanese-Western joint enterprises.
* YPC has highly reliable established-networks with licensing management
and executives of almost all large- to medium-sized Japanese pharmaceutical
companies.
|
|
* Being Japanese and versed in Japanese culture and marketplace, YPC can
provide helpful advice on transaction and negotiation with a Japanese company.
* YPC can easily get access to the first-hand information on new drugs,
drug candidates and technologies available for licensing from Japan. |
Examples of how YPC can Assist Clients |
* To most efficiently find the best partner for development and commercialization
of your products or technologies in Japan
* To evaluate the market potential of your licensing items in the Japanese
market
* To locate and acquire specific pharmaceutical products or technologies from Japan at the most efficient cost and time
|
|
* To formulate the deal structures and negotiation strategies for licensing
your products or technologies to Japan
* To answer your questions in a timely manner that you may have for licensing
and business development in Japan
|
|
